Literature DB >> 2123618

Electrophysiology of the central serotonin system: receptor subtypes and transducer mechanisms.

G K Aghajanian1, J S Sprouse, P Sheldon, K Rasmussen.   

Abstract

It is becoming evident that the diverse electrophysiological actions of 5-HT in the central nervous system can be best formulated in terms of receptor subtypes and their respective effector mechanisms. Based on the findings described in this review, the following pattern of central 5-HT electrophysiology is emerging: 1) inhibitory effects are mediated by 5-HT1 receptors linked to the opening of K channels via pertussis-toxin sensitive G proteins: 2) facilitatory effects are mediated by 5-HT2 receptors and involve the closing of K channels, an effect which appears to be negatively modulated by activation of the PI second messenger system: 3) fast excitations are mediated by 5-HT3 receptors, most likely involving a direct interaction with an ion channel rather than through coupling with a G protein or a second messenger. Further studies will be required in a wider range of brain areas to establish the generality of these conclusions.

Mesh:

Substances:

Year:  1990        PMID: 2123618     DOI: 10.1111/j.1749-6632.1990.tb16875.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  20 in total

1.  Regulation of 5-HT(1A) receptor-stimulated [35S]-GtpgammaS binding as measured by quantitative autoradiography following chronic agonist administration.

Authors:  J Hensler; H Durgam
Journal:  Br J Pharmacol       Date:  2001-01       Impact factor: 8.739

2.  Monoamine oxidase A genotype predicts human serotonin 1A receptor availability in vivo.

Authors:  Brian J Mickey; Francesca Ducci; Colin A Hodgkinson; Scott A Langenecker; David Goldman; Jon-Kar Zubieta
Journal:  J Neurosci       Date:  2008-10-29       Impact factor: 6.167

3.  Changes in the acoustic startle response and prepulse inhibition of acoustic startle in rats after local injection of pertussis toxin into the ventral tegmental area.

Authors:  J Zhang; J A Engel; S Hjorth; L Svensson
Journal:  Psychopharmacology (Berl)       Date:  1995-05       Impact factor: 4.530

4.  How Postdoctoral Research in Paul Greengard's Laboratory Shaped My Scientific Career, Although I Never Did Another Phosphorylation Assay.

Authors:  Annette C Dolphin
Journal:  J Neurosci       Date:  2021-02-08       Impact factor: 6.167

5.  Interleukin-1β causes fluoxetine resistance in an animal model of epilepsy-associated depression.

Authors:  Eduardo A Pineda; Julie G Hensler; Raman Sankar; Don Shin; Teresa F Burke; Andréy M Mazarati
Journal:  Neurotherapeutics       Date:  2012-04       Impact factor: 7.620

6.  Plasticity of presynaptic and postsynaptic serotonin 1A receptors in an animal model of epilepsy-associated depression.

Authors:  Eduardo A Pineda; Julie G Hensler; Raman Sankar; Don Shin; Teresa F Burke; Andréy M Mazarati
Journal:  Neuropsychopharmacology       Date:  2011-02-23       Impact factor: 7.853

7.  Enhancing a CH-π Interaction to Increase the Affinity for 5-HT1A Receptors.

Authors:  Jean-François Liégeois; Marc Lespagnard; Elsa Meneses Salas; Floriane Mangin; Jacqueline Scuvée-Moreau; Sébastien Dilly
Journal:  ACS Med Chem Lett       Date:  2014-01-29       Impact factor: 4.345

Review 8.  Biomarkers of epileptogenesis: psychiatric comorbidities (?).

Authors:  Andres M Kanner; Andrey Mazarati; Matthias Koepp
Journal:  Neurotherapeutics       Date:  2014-04       Impact factor: 7.620

9.  Comorbidity between epilepsy and depression: role of hippocampal interleukin-1beta.

Authors:  Andrey M Mazarati; Eduardo Pineda; Don Shin; Delia Tio; Anna N Taylor; Raman Sankar
Journal:  Neurobiol Dis       Date:  2009-11-10       Impact factor: 5.996

10.  Functional correlates of exaggerated oscillatory activity in basal ganglia output in hemiparkinsonian rats.

Authors:  Elena Brazhnik; Nikolay Novikov; Alex J McCoy; Ana V Cruz; Judith R Walters
Journal:  Exp Neurol       Date:  2014-07-30       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.